Genotyping Analysis Services
Defense Health Agency · DEFENSE HEALTH AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT942626QE044 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The US Army Army Research Institute of Environmental Medicine (USARIEM) requires requires assessing the genome of soldiers who volunteer for research studies. The Military Nutrition Division requires a vendor capable of delivering large-scale, high-density array-based genotyping services for 648 DNA samples collected as part of the Military Health and Nutrition Examination Survey (MHANES). Genomics analysis (i.e., targeted measurement of millions of Single Nucleotide Polymorphisms [SNPs] in the genome and assessment of specific SNPs) is required to support analyses in ongoing research studies.… (show all)
Genomic analysis of DNA using array-based genotyping enables targeted and reproducible measurement of hundreds of thousands to millions of known human variants and facilitates high-resolution imputation to tens of millions of additional variants. For this project, the Illumina Global Diversity Array (GDA), which includes approximately 1.8 million genome-wide markers, is required to support population genetic analyses, ancestry inference, polygenic score calculation, and genome-wide association studies (GWAS).
Who won similar work
4 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 621511.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BLOODWORKS Seattle WA 98104 USA | 1 | $4.0M | Oct 1, 2026 |
| SOPHIA GENETICS, INC. | 1 | $3.4M | Sep 26, 2025 |
| CREATIVE TESTING SOLUTIONS Tempe AZ 85282 USA | 1 | $2.3M | Mar 24, 2025 |
| I-2-I Solutions, Inc. | 1 | $328K | Dec 10, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 1, 2026BLOODWORKS Seattle WA 98104 USA$4.0MBlood Donor Testing Services
- Dec 10, 2025I-2-I Solutions, Inc.$328KAward Water Testing
- Sep 26, 2025SOPHIA GENETICS, INC.$3.4MBioinformatics at Keesler Air Force Base
- Mar 24, 2025CREATIVE TESTING SOLUTIONS Tempe AZ 85282 USA$2.3MBlood Sample Testing
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (0 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.